PharmaCast Phase 2 – Production Pilot
project
d43ab66f5559fdd6
Normalized: pharmacast phase 2 production pilot
moreland_contracts
Entity Properties (gold project table)
project_id
d43ab66f5559fdd6
name
PharmaCast Phase 2 – Production Pilot
client_id
—
canonical_metadata
—
created_at
2026-02-12 05:36:54.288209+00:00
updated_at
2026-02-12 05:36:54.288209+00:00
status
—
billable
—
recurring
—
squad
—
qa_partner
—
project_manager
—
lead_dev
—
description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
state
—
team_name
—
closedate
—
dealstage
—
contract_type
time_and_materials
contract_hourly_rate
225.0
contract_estimated_hours
500.0
contract_total_fee
112500.0
46%
Separation Confidence
How distinct this entity is from others. Higher means no close matches existed when it was created. Lower means a near-match was rejected just below the 80% threshold — worth reviewing.
Moderate — a somewhat similar entity exists
100%
Avg Match Confidence
The average confidence score across all active source mappings. Shows overall quality of linkage between source records and this canonical entity.
Strong source linkage
Source Mappings (98)
| Source | Source ID | Display Name | Confidence | Method | Status | Actions | |
|---|---|---|---|---|---|---|---|
| moreland_contracts | I74C2KfHpPt1+Q | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-03T02:06:51.478528+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | K3bDq2yqQ9U2Zg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-31T02:07:36.514570+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | HmmWaA6oNHkCRA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-26T02:08:22.017468+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | Ej6Q92fHsyzyVA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-19T15:18:19.285476+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 4KVo6v4cYQOZeQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-04T02:06:56.271454+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | XJsGdItmHtIo7Q | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-03T12:04:58.558334+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | TGvvD9WXILqMBA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-03T18:06:41.430037+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 6G0hCt6ExgiXvg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-26T12:06:52.379781+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | wU+AA7qqO0qfXw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-25T06:06:35.486494+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | quDrIIfuaSUrGw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-25T00:05:49.817028+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | fcXYMyOSimp2qg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-23T00:07:15.066605+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 9zvpgc0wp9Ehbg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-24T02:07:06.857772+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | mMrP1+gaOjjxhQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-22T02:06:23.248871+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | KQCaKelOb+f4ZA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-21T18:06:16.873710+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 7B47uih/M7LzbA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-22T12:06:08.177359+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | N7pGBqX60wuDWA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-23T18:07:04.337869+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | C0OUKLo8P+YswQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-25T02:06:10.191299+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 6B3XukTm+9d6BQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-02T18:05:57.412207+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | cELQ3+RA8I/lRA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-03T06:05:44.440451+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 0FiUBkcGdjLIDA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-05T00:05:28.746186+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 7U1ftnUhhq5uBw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-05T02:06:29.638013+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | MnqS5wsBKPqN5g | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-23T02:07:11.824262+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | bythZqwvR3Yhdg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-25T02:08:02.293672+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | NCxqZahzJOfihA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-30T02:08:00.330473+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 3cXwvbeKYt0Evg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-08T02:07:12.143902+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | iM89SsDQC91xwQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-04-02T02:07:14.696409+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | B03q48xI/GeAwQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-24T02:07:05.932169+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 6SfWG4XlWAgObw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-06T12:06:09.090773+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | PTG/uFfYHzadVw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-06T02:06:31.525085+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 1/tOHmuLL3sD6A | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-04T12:06:19.714910+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | EJR6ihtdlaNu0Q | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-03T02:06:49.298040+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | H9L1O1wukIqWUQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-26T00:06:32.107609+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | oGdqATZpiaE9gA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-24T12:06:09.705107+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | DEaVasPSkx5iBg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-19T03:12:25.521037+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | FSuB2aM/LCajIg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-22T00:05:52.888432+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | hFczZUBAwmasCQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-21T12:06:09.915253+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | e3nEbxTI35toNw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-19T18:06:38.385093+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 7gvzUicmSdNwmQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-21T00:07:12.758811+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | s50+PGZpkhuOVQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-20T00:05:33.395716+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | Vout3MLZhQ6MUA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-20T12:06:21.197581+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | ZGXIq9DZ7oOCEw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-26T18:06:21.715528+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | OfgFdbcof3Ew5Q | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-04T00:06:35.715022+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | UGjXtEBuf7ayog | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-05T12:06:53.191212+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | /rrzrOR1yJjC7Q | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-19T21:23:16.488865+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | VhZZMnPG+0IZ7w | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-21T02:07:20.005447+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | uMx/QB1B/r9gww | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-09T02:06:20.648868+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | O9kuXP1KOFuBbQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-05T02:06:48.225618+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 1PuEAohS7awrCw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-04T02:07:36.538714+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | h7iA8toAa3Jccw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-06T06:06:02.161467+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | u3w0cWVEaLMf0g | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-04T06:07:33.392046+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | LJcN+5Lms/sJJg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-03T00:05:43.620563+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | iTxjJ2HMWFsb3g | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-24T00:06:01.644231+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | KXUVx3IT2NNqCA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-19T03:10:19.669354+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | Iq0vptGYYp0snQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-21T06:06:23.479343+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | clz3TBMDkTGBUw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-20T06:06:23.483708+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | O6lS11TPgDoYrw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-24T18:06:34.164018+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | xELF+S0rGEgC3g | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-24T06:06:15.998095+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | vjIinTrn5juCxQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-06T02:07:06.193478+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | j7PT2wWCeiL5ww | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-08T21:09:28.432980+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | kaxAKa8uprrgNg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-27T02:07:27.501978+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | gSi3CqWvttwuVg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-20T02:06:38.149851+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | e2b5uuIStOJHiw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-04T18:06:46.599629+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | zkFOceG/L8B5aw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-02T17:49:51.697599+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | p7gkXrujeL/izQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-25T18:06:58.412151+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | f3Bz5eUW8O0Odw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-26T02:06:31.842100+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | KyZXnXRLCdhuig | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-25T12:06:14.921922+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | HFt401sns0jezQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-23T06:07:36.294085+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | fDsBBpOFMBHgTw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-20T02:07:12.212063+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | I+yS620UsMZ2vA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-19T06:06:37.226874+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | hJdu4ED+t0XiCA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-19T12:06:43.423816+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | kBr5AsUl+xaOVw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-22T06:05:31.376629+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | mJfSt8U0M+nbrg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-21T02:06:45.901963+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | fW1JgDAdwKEPgA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-20T18:05:49.551493+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | soWuw1uuC64ylQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-02-23T12:06:16.038218+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 7UjFvT/HtVQMkw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-02-23T02:06:38.955215+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | MOLt9j+TLeYXqg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-02T17:49:38.451827+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 1RoI1WMpTR65Ww | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-05T06:06:07.157560+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | TJbKu3V9MlJQ/A | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-03-06T00:06:13.712465+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | YIiX8yt19UhUjQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-22T02:06:37.628978+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | gSgIms9z7bsXNg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-28T02:07:45.833417+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | cgea/eqpEX5qpA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-03-29T02:06:39.459819+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | UZtu3GtbjCo20w | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-04-01T02:08:19.563618+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | RuNDifi/RWS3JQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-04-07T02:07:36.271346+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 1n3FJhQWJWaCsg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-04-10T02:07:20.690866+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | FPGGH9EpIx8DjA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-04-11T02:06:23.204824+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | dSbmq4SreN7xLQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-12T02:05:52.468203+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | eTv/KFTHiVYTkw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-13T02:06:54.255816+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 5BMTYB3yUT0MDg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-04-14T02:06:47.045740+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | Jn1RlQF1Gq+DBQ | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-04-23T02:07:11.486158+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | WTUAvofUnWKNtw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-15T02:06:36.557819+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | bicZcjcULm2VZw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-04-16T02:06:53.001006+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | EC/v6J5WjWeAqw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-17T02:06:29.726528+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | DdhiOstbFA2fxw | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-18T02:06:46.061055+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | ZERcUv8tVtmSFg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-19T02:05:52.233921+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | WpLMxMLz6iUeVg | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-04-20T02:06:58.625451+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 4Y8AtOYfep43Ig | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform.
start_date
—
extracted_at
2026-04-21T02:06:26.289141+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | 2oTh/lxzWfkhFA | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-22T02:07:32.955947+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||
| moreland_contracts | qx/cDsPB8Hf87w | PharmaCast Phase 2 – Production Pilot | 1.00 | exact | Active |
|
|
|
Source Record
bronze_moreland_contracts_ma_project_contracts
file_hash
a7a58d1690b77595c5c980a4986d947c
file_name
Seeber Farms PharmCast Phase 2 - Moreland Arrangement Letter.docx
file_path
https://morelandpartners.sharepoint.com/sites/MorelandConnect-BusinessDevelopment/_layouts/15/Doc.aspx?sourcedoc=%7B8167BEF1-05F8-4D54-BDB3-833AD7597739%7D&file=Seeber%20Farms%20PharmCast%20Phase%202%20-%20Moreland%20Arrangement%20Letter.docx&action=default&mobileredirect=true
company
Seeber Lifesciences, LLC
project_name
PharmaCast Phase 2 – Production Pilot
contact_person
Eric Camastro
contract_type
time_and_materials
hourly_rate
225.0
estimated_hours
500.0
total_fee_estimate
112500.0
brief_project_description
Design, development, and deployment of the PharmaCast Production Pilot, a professional-grade forecasting platform incorporating advanced AI research.
start_date
—
extracted_at
2026-04-09T14:00:22.259439+00:00
raw_text_preview
December 3, 2025
Eric Camastro
Seeber Lifesciences, LLC
1304 Becket Dr.
Brookhaven, Georgia 30319
Re: PharmaCast Phase 2 – Production Pilot
Dear Eric:
MorelandConnect LLC (“Moreland”) is pleased to provide this Arrangement Letter (“Agreement”) confirming our consulting services (the “Services”) to assist Seeber Lifesciences, LLC f/k/a Seeber Farms Management (“Seeber”) with the design, development, and deployment of the PharmaCast Production Pilot—a pilot-ready, professional-grade forecasting platform incorporating advanced AI research, refined forecasting capabilities, and a production-quality user experience.
Project Description
1. Objective
The goal of this engagement is to design, build, and deliver the PharmaCast Production Pilot, enabling Seeber to launch a polished, production-grade pilot version of the PharmaCast forecasting platform to present to potential strategic acquirers. This staged-investment approach provides rapid time-to-feedback, reduced risk, and ensures development dollars are allocated to high-value capabilities.
2. Scope of Work
The engagement consists of designing, developing, and deploying the Production Pilot tier, including substantial refinement and commercialization of core capabilities. The scope includes:
A. PubMed AI Research Agent – Full Production Implementation (Highest Priority)
Moreland will build and refine the platform’s signature capability—the PubMed AI Research Agent, the differentiating feature of PharmaCast. PubMed is the primary data source, but other government datasets such as SEER and NIMH may be used to provide additional data to the AI Research Agent.
Work includes:
Deep PubMed API integration with optimized performance
Advanced query handling, rate limiting, resilience, and error recovery
Sophisticated prompting for epidemiology data extraction
Intelligent parsing with confidence scoring
Professional-grade citations, provenance tracking, and source linking
B. Enhanced Forecast UI (High Priority)
Moreland will d
file_created_at
2025-11-11T21:07:51+00:00
file_modified_at
2026-01-08T15:14:22+00:00
created_by
Jeff Kavlick
modified_by
Jeff Kavlick
_dlt_meta
—
|
|||||||